A targeted therapy drug used for breast and kidney cancers may also extend progression-free survival for patients with advanced head and neck cancer who are at high risk for recurrence after standard treatment. Patients enrolled ...
Feb 27, 2020
0
0
An experimental drug already shown to be safe and help some patients with clear cell renal cell carcinoma, a deadly form of kidney cancer, effectively disables its molecular target. The finding from a team of researchers ...
Feb 20, 2020
0
30
By identifying the role of a specific protein in the development of obesity-related liver diseases, UNIGE researchers pave the way for better diagnosis, and potentially better treatment.
Feb 19, 2020
0
3
An Indiana University cancer researcher has identified eight new genomic regions that increase a person's risk for skin cancer.
Feb 19, 2020
0
58
The cause of a disease often affects its treatment plan. The need to fill this gap in our understanding of disease biology is further exaggerated in the case of 'rare' diseases.
Feb 18, 2020
0
1
Scientists report promising activity of a novel drug that targets a key molecular driver of clear cell renal cell carcinoma in patients with metastatic disease.
Feb 13, 2020
0
1
Researchers at the University of Turku, Turku University Central Hospital, and Western Cancer Center (FICAN West) have discovered a new RNA molecule, PRECSIT, which regulates the growth and invasion of squamous cell carcinoma ...
Feb 4, 2020
0
1
The cover for issue 3 of Oncotarget features Figure 3, "Hierarchical clustering of tonsil squamous cell carcinoma cohorts based on viral signature detection pattern with associated pathological features (perineural invasion ...
Jan 27, 2020
0
5
Worldwide, the incidence rate of skin cancer, like other types of cancer, is increasing. People in Europe and the Nordic countries are, compared to other areas of the world, at a higher risk of developing skin cancer due ...
Jan 27, 2020
0
3
The Cutaneous Oncology Program at the George Washington University (GW) Cancer Center was selected as the first global site for a clinical trial for patients with high-risk cutaneous squamous cell carcinoma. This designation ...
Jan 23, 2020
0
2
